For people living with depression, medication and therapy can be life-changing. But for others, those traditional options don ...
Trump said on Saturday the directive would “dramatically accelerate” access to research and potential treatments.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...
The president offered FDA approval for accelerated research of the psychedelic by text, podcaster Joe Rogan told reporters ...
This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, ...
President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...
Emerging evidence suggests nitrous oxide provides rapid relief for treatment-resistant depression. But is the therapy ready ...
When Jason Prinzo was diagnosed with depression, he was five years old. His father was an alcoholic and a drug addict who was ...
President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already ...
The first drug for women suffering postpartum depression received federal approval on Tuesday, a move likely to pave the way for a wave of treatments to address a debilitating condition that is the ...
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson‘s Caplyta as an add-on treatment for adults with major depressive disorder. Following the FDA’s Nov. 5 decision ...
SAN FRANCISCO, California -- For the first time, the FDA has approved a medication specifically to treat new mothers who suffer from postpartum depression. The drug is called Brexanolone and will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results